Serratia liquefaciens: PCR Detection and Clinical Overview

Serratia liquefaciens is a Gram-negative, short rod-shaped bacterium measuring approximately 0.5–0.8 μm in width and 1.0–3.0 μm in length. Cells have rounded ends and typically occur singly or occasionally in pairs.

The organism is non-spore-forming and lacks a capsule. A key distinguishing feature is the presence of peritrichous flagella, which confer strong motility and allow the bacterium to spread across semi-solid media.

Metabolically, Serratia liquefaciens is a facultative anaerobe with broad adaptability to oxygen conditions. It can utilize a variety of carbohydrates, including glucose, lactose, and sucrose, producing both acid and gas during fermentation. These metabolic traits are important for biochemical identification.

Serratia liquefaciens is widely found in soil, water, and various environmental niches, as well as in hospital settings. Its ability to adapt to different environmental conditions makes it a persistent organism in both natural ecosystems and healthcare environments.

In clinical settings, it may colonize medical devices and surfaces, contributing to nosocomial infections. Transmission is typically associated with contaminated equipment, fluids, or surfaces, particularly affecting immunocompromised individuals.

Due to its environmental sensitivity and responsiveness to changing conditions, it is also used as a model organism in environmental quality monitoring.

Serratia liquefaciens is considered an opportunistic pathogen and can cause a variety of infections, particularly in hospitalized or immunocompromised patients. These include respiratory tract infections, urinary tract infections, wound infections, and bloodstream infections.

The clinical significance of this organism lies in its ability to survive in hospital environments and contribute to healthcare-associated infections, especially when infection control measures are inadequate.

Serratia liquefaciens can be cultured on standard media such as blood agar, MacConkey agar, and nutrient agar. Optimal growth occurs at 35–37°C, with visible colonies forming after 18–24 hours.

On blood agar, colonies are typically circular, smooth, moist, and glossy with diameters of 1–3 mm. Some strains may produce beta-hemolysis and develop pink or red pigmentation over time.

On MacConkey agar, due to lactose fermentation and acid production, colonies appear pink or red, providing a useful initial identification marker in mixed cultures.

While phenotypic methods provide preliminary identification, molecular techniques such as PCR and real-time qPCR offer rapid, sensitive, and specific detection of Serratia liquefaciens. These methods are critical for accurate diagnosis and monitoring in both clinical and environmental applications.

Management of infections caused by Serratia liquefaciens requires antimicrobial susceptibility testing due to potential variability in resistance profiles. Appropriate antibiotic selection is essential for effective treatment.

In healthcare settings, prevention focuses on strict infection control practices, including sterilization of medical equipment, environmental hygiene, and monitoring of high-risk patients.

In environmental contexts, surveillance of Serratia liquefaciens can provide valuable insights into ecosystem health and contamination dynamics.